Emergent BioSolutions to Release Third Quarter and Nine Months 2017 Financial Results and Conduct a Conference Call on Novemb...
October 19 2017 - 7:00AM
Emergent BioSolutions (NYSE:EBS) will release its financial results
for the third quarter and nine months of 2017 immediately after
market close on Thursday, November 2, 2017. The company will also
host a conference call at 5:00 pm (Eastern Time) at which time
members of management will discuss these results, as well as recent
business developments, revenue and net income guidance for full
year 2017 and revenue guidance for fourth quarter 2017.
This conference call can be accessed live by telephone or via
webcast:
Live Teleconference
Information:Dial in number:
(855) 766-6521Conference ID:
29706026
Live Webcast Information:Visit
https://edge.media-server.com/m6/p/dvysvtww for the live webcast
feed.
A replay of the call can be accessed on Emergent’s website
emergentbiosolutions.com under “Investors.”
About Emergent BioSolutionsEmergent
BioSolutions Inc. is a global life sciences company seeking to
protect and enhance life by focusing on providing specialty
products for civilian and military populations that address
accidental, intentional, and naturally emerging public health
threats. Through our work, we envision protecting and enhancing 50
million lives with our products by 2025. Additional information
about the company may be found at emergentbiosolutions.com. Follow
us @emergentbiosolu.
Investor Contact:Robert G.
BurrowsVice President, Investor
Relations240-631-3280BurrowsR@ebsi.com
Media Contact:Lynn KiefferVice
President, Corporate Communications
240-631-3391KiefferL@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024